Location History:
- Broomfield, CO (US) (2004 - 2013)
- Golden, CO (US) (2013 - 2023)
Company Filing History:
Years Active: 2004-2023
Title: The Innovative Contributions of Samuel T. Henderson
Introduction
Samuel T. Henderson, located in Golden, Colorado, is a notable inventor with a remarkable portfolio of 12 patents to his name. His work primarily focuses on pharmaceutical compositions and methods that aim to improve cognitive function, particularly in relation to diseases such as Alzheimer's.
Latest Patents
Among Henderson's latest inventions are two significant patents that explore the therapeutic potential of medium chain triglycerides (MCT). The first patent, titled "Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto," discusses compositions designed to elevate ketone body concentrations. This treatment approach is particularly aimed at improving conditions associated with reduced neuronal metabolism, such as Alzheimer's disease.
His second patent, "Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II," refines methods for treating or preventing senile dementia of the Alzheimer's type. It describes how administering triglycerides or fatty acids with chain lengths between 5 and 12 can significantly enhance cognitive abilities in patients.
Career Highlights
Throughout his career, Samuel T. Henderson has made significant contributions in the field of pharmaceutical research. He has worked with prominent organizations such as Accera, Inc. and Cerecin Inc., where he furthered his research and innovation efforts in addressing cognitive decline and related conditions.
Collaborations
Henderson’s collaborations with esteemed colleagues, including Aaron Badenoch and Taryn Boivin, have undoubtedly contributed to the advancement of his innovative work. Their joint efforts in research enhance the potential impacts of his inventions on improving patient outcomes in neurodegenerative diseases.
Conclusion
Samuel T. Henderson’s innovative spirit and dedication to addressing crucial health challenges through his inventions are commendable. His patents not only reflect a commitment to scientific advancement but also provide hope for improving the quality of life for those affected by Alzheimer's disease and other cognitive conditions. As he continues to innovate, the potential for positive change in the pharmaceutical landscape remains promising.